Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Nocturnal Hypertension and Nocturia in African American Men
NCT03319823Phase 4Withdrawn
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Oct 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indapamide, telmisartan, amlodipine in hypertension (HTN), nocturia, sponsored by Cedars-Sinai Medical Center. Planned start Oct 2017; status: withdrawn.
02
Drugs
indapamidetelmisartanamlodipine
03
Conditions
hypertension (HTN)nocturia
Beyond the preview
Go deeper on NCT03319823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03319823.